# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1680932 | F | Agonist activity at human GPR109b | Homo sapiens | 3 | assay format | Scientific Literature | ||
2. | ALA1680933 | A | AUC (0 to 6 hrs) in rat at 10 mg/kg, po | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
3. | ALA1680934 | F | Agonist activity at cynomolgus monkey GPR109a | Macaca fascicularis | 3 | assay format | Scientific Literature | ||
4. | ALA1680935 | F | Agonist activity at rat GPR109a | Rattus norvegicus | 3 | assay format | Scientific Literature | ||
5. | ALA1680936 | F | Agonist activity at mouse GPR109a | Mus musculus | 3 | assay format | Scientific Literature | ||
6. | ALA1680937 | F | Agonist activity at dog GPR109a | Canis lupus familiaris | 3 | assay format | Scientific Literature | ||
7. | ALA1680938 | F | Antihyperlipidemic activity in Beagle dog assessed as reduction of plasma free fatty acid level at 1 mg/kg, po after 1 hr | Canis lupus familiaris | 3 | organism-based format | Scientific Literature | ||
8. | ALA1680940 | F | Antihyperlipidemic activity in Sprague-Dawley rat assessed as reduction of plasma triglyceride level at 1 mg/kg, po after 1 hr | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
9. | ALA1680942 | B | Binding affinity to GPR109b | 2 | single protein format | Scientific Literature | |||
10. | ALA1680943 | F | Antihyperlipidemic activity in Sprague-Dawley rat assessed as reduction of plasma free fatty acid level at 1 mg/kg, po after 1 hr | Rattus norvegicus | 2 | organism-based format | Scientific Literature | ||
11. | ALA1680944 | F | Agonist activity at human recombinant GPR109a expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation | Homo sapiens | 48 | cell-based format | Scientific Literature |